- Citations, last 5 years
- 55
- Works, last 5 years
- 18
- h-index
- 135
- Scientists listed
- 3
- Grants since 2016
- 11
Grants received
2024–2025 · research · R41
Engineering Chemically Modified RNPs for Effective Treatment of Angelman Syndrome
Ying Xie · Asuragen (United States) · funded by National Institutes of Health
2019–2021 · research · R43
Novel Strategies for Development of a Multiplexed Test with Expanded Content for Spinal Muscular Atrophy
Huiping Zhu · Asuragen (United States) · funded by National Institutes of Health
2019–2020 · research · R43
A single test utilizing a unified multiplex PCR/CE workflow targeting five dominant inherited ataxias
Bradley Hall · Asuragen (United States) · funded by National Institutes of Health
2019–2021 · research · R43
Novel Strategies for Enhanced Detection of Hemoglobinopathy Carriers
Sarah Nicole Statt · Asuragen (United States) · funded by National Institutes of Health
2019–2021 · research · R43
Single cell prenatal testing of circulating trophoblasts using a the novel immunomagnetic Micro-Aperture Chip (IMAC) system
Liangjing Chen Chen · Asuragen (United States) · funded by National Institutes of Health
2019–2021 · research · R43
AmplideX DeepNet, a new paradigm for deep learning analytical tools in the molecular diagnostic space
Jessica Lynn Larson · Asuragen (United States) · funded by National Institutes of Health
2018–2019 · research · R43
Novel strategies for enhanced analysis of repeat disorders
Sarah Nicole Statt · Asuragen (United States) · funded by National Institutes of Health
2018–2020 · research · R43
Development of a unified information-rich test for CNBP and DMPK to improve assessment of Myotonic Dystrophy Type 1 and 2
Bradley Hall · Asuragen (United States) · funded by National Institutes of Health
2018–2020 · research · R43
Improving rare variant detection in next generation sequencing of liquid biopsies with a molecular barcoding technique that combines a novel primer structure and sophisticated bioinformatics methods
Jessica Lynn Larson · Asuragen (United States) · funded by National Institutes of Health
2017–2019 · research · R43
Development of a unified Alzheimer's disease test that combines high resolution analysis of TOMM40 and Apolipoprotein E for improved risk estimates
Sarah Nicole Statt · Asuragen (United States) · funded by National Institutes of Health
2014–2020 · research · R44
Development of an information-rich assay for C9ORF72 as a test for ALS and FTD
Sarah Nicole Statt · Asuragen (United States) · funded by National Institutes of Health